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Abstract
The number of receptors of the `C-type' lectin family is greater than previously thought with a
considerable proportion on cells (dendritic cells and macrophages) critical for innate immunity.
Establishing that they bind carbohydrates, unravelling and comparing details of their ligands is
crucial for understanding the molecular basis of the cell±cell and cell±pathogen interactions that
they mediate. Here we use carbohydrate arrays as a new approach to discovering the ligands of
three recently described C-type lectin-type receptors on antigen-presenting cells: murine SIGN-R1,
SIGN-R3 and langerin. The arrays encompass an extensive panel including polysaccharides,
glycoproteins, oligosaccharides and monosaccharides. These are probed with soluble forms of the
receptors (IgG±Fc chimeras). The dominant speci®cities found for SIGN-R1 and SIGN-R3 are
mannose- and fucose-related, as expressed on high mannose type N-glycans and Lewisa/b/Lewisx/y-
type sequences, respectively, with subtle differences between the receptors. The dominant
speci®city for langerin is unique so far: a Lewisx-related sequence with sulfate at position 6 of the
terminal galactose. The polysaccharide dextran, known from classical studies to elicit a
T-independent response, and whose cellular uptake has been shown recently to be mediated by
membrane-associated SIGN-R1, gave no binding signals with the soluble form of the protein. We
highlight here the additional need for cell-based assays for detecting biologically relevant low
af®nity ligands, for we show with SIGN-R1-transfected cells that dextran is such a low af®nity
ligand for SIGN-R1 that binding is detectable only with the cell membrane-associated receptor. But
there is a close relationship between dextran recognition and mannose/fucose recognition, with
dextran- and mannose-conjugates co-localizing in intracellular compartments.
Introduction
Carbohydrate-binding proteins of the `C-type' lectin and
Siglec families are intimately involved in mechanisms of cell
traf®cking in in¯ammation, immune cell activation, pathogen
recognition and innate immunity (1±5). A sub-family of C-type
lectins, newly discovered on antigen-presenting cells, has
become the subject of exciting research at the interface of
innate and acquired immunity (6,7). In the human, these
include the receptor known as DC-SIGN expressed mainly in
immature dendritic cells (DCs) (8,9), langerin in Langerhans
cells (10), and L-SIGN in endothelial cells (11).
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Information is accumulating on the carbohydrate ligands for
the new family of lectins on antigen presenting cells. In the
human, DC-SIGN, L-SIGN and langerin have been shown to
recognize oligosaccharides with terminal mannose or fucose
(12±16), and to variously exhibit carbohydrate-mediated
interactions with glycoconjugates of the host and of microbial
pathogens (7,17). Among the proposed outcomes of DC-
SIGN interactions with counter-receptors in the host are the
regulation of transendothelial migration of DCs through inter-
actions with ICAM-2 (18), and a contribution to T-cell activation
and proliferation through interactions with ICAM-3 (8). Among
sequelae of DC-SIGN±pathogen interactions are the sub-
version of DC functions for pathogen escape from immune
surveillance (19). Examples include the retention of HIV by
DCs without killing, and the subsequent transmission of
the virus to susceptible T cells (20,21) and promotion of
persistence of Mycobacterium tuberculosis in DCs (22).
In the mouse, six related proteins have been cloned: DC-
SIGN (23) and langerin (24) predominantly in DCs, and four
SIGN-related genes, SIGN-R1, SIGN-R2, SIGN-R3 and SIGN-
R4, in other cell types of the immune system (23). SIGN-R1 is
expressed on medullary and subcapsular macrophages in
lymph nodes (25) and on marginal zone macrophages
(MZMs) (25,26). In classical studies, more than a decade
before the discovery of SIGN-R1, and its assignment as a
lectin-type molecule, it was recognized that bacterial poly-
saccharides such as dextran elicit T-cell independent anti-
body responses (27±30). It is now established that SIGN-R1 is
a key receptor that mediates the uptake of dextran. Now that
other receptors of this family have been described on antigen
presenting cells, it is important to unravel and compare details
of their carbohydrate ligands. This is a prerequisite for
understanding the molecular basis of the cell±cell as well as
cell±pathogen interactions that they mediate, thereby in¯uenc-
ing innate and acquired immunity. This could open the way to
manipulating these interactions therapeutically. The pinpoint-
ing of oligosaccharide ligands, however, remains a challeng-
ing area of cell biology (31). This is because ligands that are
oligosaccharides cannot be readily cloned, each being the
product of multiple glycosyltransferases. Thus there is a need
for sensitive and high throughput technologies to perform
analyses of carbohydrate±protein interactions in order to
detect and characterize the oligosaccharide sequences
bound.
Microarray approaches, analogous to those developed for
DNA (32), and being developed for proteins (33), are ideal for
addressing this need. Only small amounts of products are
required for generating microarrays and many compounds
can be screened in parallel in a single operation. Indeed, array
technology is a new development in glycobiology and
immunology. The special advantage is that it enables diverse
carbohydrates (polysaccharides, glycoproteins, monosac-
charides as well as de®ned oligosaccharide sequences) to
be probed simultaneously with carbohydrate-binding proteins
(34). Recent reports of `proof of concept' experiments with
known carbohydrate-recognizing proteins have shown there is
selectivity of binding to arrayed carbohydrates. Thus, the
predicted binding signals have been recorded with well
characterized carbohydrate-recognizing antibodies (35±37),
the selectins, a cytokine, a chemokine (36) and several plant
lectins (38±40). A carbohydrate array system consisting of
lipid-linked oligosaccharide probes derived from natural and
chemically synthesized oligosaccharides (36) has shown
promise as a powerful means of generating large repertoires
of oligosaccharide sequences both for detecting protein±
carbohydrate interactions and assigning the sequences
recognized.
Here we describe the use of carbohydrate arrays to identify
and compare the carbohydrate ligands for three recently
described receptors of the immune system, murine SIGN-R1,
SIGN-R3 and langerin. This was carried out by probing
recombinant soluble forms of the proteins, IgG Fc chimeras,
with arrays of monosaccharides, polysaccharides, glyco-
proteins and de®ned oligosaccharide sequences. In the
course of this work, we have found no detectable dextran
binding by the soluble form of the SIGN-R1 (nor of SIGN-R3
and langerin) although it had been clearly demonstrated
previously, using SIGN-R1-transfected cells, that this receptor
mediates the cellular uptake of the polysaccharide dextran
(25,26). We have therefore carried out detailed carbohydrate-
binding studies with cell transfectants expressing the mem-
brane-associated protein. The results provide the explanation
that, compared with other carbohydrate ligands with mannose
and fucose termini, dextran has a very low af®nity for SIGN-R1.
Thus, the cell-based approach complements the array
approach for ligand assignment, and may be necessary for
detecting biologically relevant, low af®nity, ligands that cannot
be detected with the soluble receptor, even after multi-
merization.
Methods
Carbohydrate materials
The monosaccharides mannose, galactose and fucose, and a
FITC-labelled neoglycoprotein, galactose linked to BSA, 15±
20 moles monosaccharide per mole of albumin, were from
Sigma (Dorset, UK). Biotinylated neoglycoconjugates of
mannose and galactose linked to polyacrylamide (PAA), Mr
~30 000, were from Syntesome (Moscow, Russia), and are
said to contain, on average, 20% mol monosaccharide. The
following BSA±monosaccharide conjugates were gifts of
Professor Y.C. Lee (Department of Biology, Johns Hopkins
University, Baltimore, MD): mannose (BSA±Man23), glucose
(BSA±Glc25), fucose (BSA±Fuc23), galactose (BSA±Ga23),
N-acetylglucosamine (BSA±GlcNAc23) and N-acetylgalactos-
amine (BSA±GalNA23); the subscripts indicate the number of
moles of the monosaccharides per mole of BSA. The
glycoproteins ribonuclease B, invertase, soybean agglutinin,
ovalbumin, fetuin and asialofetuin, and the polysaccharides
heparan sulfate, heparin, fucoidan, Ficoll, yeast mannan,
dextrans of 10 kDa, 70 kDa and 2000 kDa, and dextran sulfate
were from Sigma. Bovine articular cartilage keratan sulfate
was from Dr Gavin Brown (Department of Biological Sciences,
Lancaster University, UK). The polysaccharide of Escherichia
coli, serotype K5 was from Camilla Westling (Department of
Medical Biochemistry and Microbiology, Uppsala University,
Sweden). FITC-conjugated dextrans of molecular mass
10 kDa, 70kDa, and 2000 kDa (dextrans 10K-F, 70K-F and
2000K-F), Texas-red conjugated dextran of molecular mass
854 Carbohydrate arrays and ligands of SIGN-R1, -R3 and langerin
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70 kDa (dextran-70K-TR) and biotinylated dextran molecular
mass 500 kDa were from Molecular Probes (Leiden, The
Netherlands). The main carbohydrate sequences on the
arrayed glycoconjugates are described in Table 1.
The lipid-linked oligosaccharides investigated are listed in
Table 2. Unless otherwise stated, they are the compounds
described in (36). The Lewisx (Lex) glycolipid (GL), hexa-
glycosyl-ceramide with sialic acid at position 6 of galactose,
6¢-SA-Lex-5 (oligosaccharide no. 63) was chemically synthe-
sized (41). The high mannose N-glycans Man3, Man4a,
Man4b, Man5, Man6, Man7D1, Man7D3, Man8, Man9,
Man3F, and complex-type biantennary NA2, NGA2 and
NA3-Lex were gifts from Dr Vladimir Piskarev (Nesmeyanov
Institute of Organoelement Compounds, Moscow, Russia).
The blood group A trisaccharide (A-tri) was from Dextra
laboratories (Reading, UK) and blood group B-pentasac-
charide (B-penta) from Oxford GlycoSystems (Abingdon, UK).
Dextran fragments tetra-, penta-, hexa- and heptasaccharides
were isolated from an acid hydrolysate of dextran. Chitotriose
was from Sigma. The Lex pentasaccharides with sulfate at
position 6 of galactose, 6¢-SU-Lex-5 and with sulfate at
positions 3 and 6 of galactose, 3¢,6¢-SU-Lex-5 (oligosac-
charides no. 62 and 61; Table 2) were chemically synthesized
and were gifts from Professor Andre Lubineau (Department of
Chemistry, University of Orsay, France). These reducing
oligosaccharides were conjugated to 1,2-dihexadecyl-sn-
glycero-3-phosphoethanolamine to form neoglycolipids
(NGLs) as described (42). The NGL of 6¢-SU-LNNT (no. 64)
was prepared by mild acid treatment of the NGL of 6¢-SU-
Lex-5.
Recombinant proteins
The extracellular portions of murine SIGN-R1, SIGNR3 and
langerin were expressed as soluble proteins fused to the
Table 1. Designations and locations on the array of the monosaccharide-conjugates, glycoproteins and polysaccharides
investigated, and semi-quantitative scores of the binding by soluble SIGN-R1, SIGN-R3 and langerin
Samples Typea Locationb Main or representative sequencesc SIGN-R1d SIGN-R3 Langerin
1 BSA-Man NGP a1 Ma ++ +/± ±
2 BSA-Glc NGP a2 Gc ± ± ±
3 BSA-Fuc NGP a3 Fu + + ±
4 BSA-Gal NGP a4 Ga ± ± ±
5 BSA-GlcNAc NGP a5 GcN +/± ± ±
6 BSA-GalNAc NGP b1 GaN ± ± ±
7 PAA-Gal NGC b2 Ga ± ± ±
8 PAA-Man NGC b3 Ma + +/± +/±
9 RNAse B GP b4 Maa-6(Maa-3)Maa-6(Maa-3)Mab-4GcNb-4GcN ± ± +/±
10 Invertasee GP b5 -6(Ma-2)Ma-6(Ma-2Ma-2)Ma-6(Ma-3Ma-2)Ma-
6(Ma-3Ma-2Ma-2)Ma-GcN-4GcN
+++ + ±
11 Soybean agglutinin GP c1 Maa-2Maa-6(Maa-3)Maa-6(Maa-2Maa-2Maa-
3)Mab-4GcNb-4GcN
++* ++* +/±*
12 Ovalbumin GP c2 Maa-6(Maa-3)Maa-6(Maa-2Maa-3)Mab-4GcNb-
4GcN
+ ± +/±
13 Fetuine GP c3 SA-3/6Ga-4GcN-2(SA-3/6Ga-4GcN-4)Ma-3(SA-3/
6Ga-4GcN-2Ma-6)Ma-4GcN-4GcN
± ± ±
14 Asialofetuin GP c4 Gab-4GcNb-2(Gab-4GcNb-4)Maa-3(Gab-4GcNb-
2Maa-6)Mab-4GcNb-4GcN
± ± ±
15 HS PS c5 -[4GcAb-4GcN(6SU)a]n, -[4IdA(2SU)a-
4GcN(2,6SU)a]m-
± ± ±
16 K5 PS d1 -[4GcAb-4GcNa]n- ± ± ±
17 Fucoidan PS d2 -[3(Fua-4)Fua-3Fua-3Fua(4SU)-3Fua-3(Fua-
2)Fu(4SU)a]-
± ± +/±
18 Ficoll PS d3 (Gca-2Fra-)n ± ± ±
19 Yeast mannane PS d4 -[6(Ma-2)Ma-6(Ma-2Ma-2)Ma-6(Ma-3Ma-2)Ma-
6(Ma-3Ma-2Ma-2)Ma]-
+ ± ±
20 Dextran 2000K PS d5 -[6Gca-6Gca]n- ± ± ±
21 Dextran 70K PS e1 -[6Gca-6Gca]n- ± ± ±
22 Dextran 10K PS e2 -[6Gca-6Gca]n- ± ± ±
23 Dextran 2000K-F PS e3 -[6Gca-6Gca]n- ±* ±* ±*
24 Dextran 70K-F PS e4 -[6Gca-6Gca]n- ± ± ±
25 Dextran 10K-F PS e5 -[6Gca-6Gca]n- ± ± ±
26 Dextran 70K-TR PS f1 -[6Gca-6Gca]n- ±* ±* ±*
27 Dextran SU-500K PS f2 -[6Gca-6Gca]n-, sulfated ++ ++ ++
aAbbreviations for glycoconjugates and their ¯uorescent tags: F, FITC; GP, glycoprotein; NGP, neoglycoprotein; NGC, neoglycoconjugate;
PS, polysaccharide; TR, Texas red.
bRefers to location on array.
cAbbreviations for monosaccharide residues and substituents: Fr, fructose; Fu, fucose; Ga, galactose; GaN, N-acetylgalactosamine;
Gc, glucose; GcA, glucuronic acid; GcN, N-acetylglucosamine; IdA, iduronic acid; Ma, mannose; SA, sialic acid; SU, sulfate.
dSemi-quantitative visual scores for binding signals detected: +++, very strong; ++, strong; + moderate; +/±, weak; ±, not detected.
* = scores of binding signals above those elicited with the control protein, mouse Ig Fc.
eDue to space limitation, anomeric con®gurations of monosaccharide residues are not shown for these glycans.
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Table 2. Designations and locations of the carbohydrate-containing molecules investigated, and semi-quantitative scores of
the binding by the soluble SIGN-R1, SIGN-R3 and langerin
Oligosaccharides Typea Locationb Sequences or compositionsc SIGN-R1d SIGN-R3 langerin
28 N-glycan: Man3 NGL g1 Maa-6(Maa-3)Mab-4GcNb-4GcN + ± ±
29 N-glycan: Man4a NGL g2 Maa-3Maa-6(Maa-3)Mab-4GcNb-4GcN ++ ± ±
30 N-glycan: Man4b NGL g3 Maa-6(Maa-3)Maa-6Mab-4GcNb-4GcN ++ ± ±
31 N-glycan: Man5 NGL g4 Maa-6(Maa-3)Maa-6(Maa-3)Mab-4GcNb-4GcN +++ + ±
32 N-glycan: Man6 NGL g5 Maa-6(Maa-3)Maa-6(Maa-2Maa-3)Mab-4GcNb-4GcN ++ + ±
33 N-glycan: Man7D1 NGL h1 Maa-6(Maa-3)Maa-6(Maa-2Maa-2Maa-3)Mab-4GcNb-4GcN ++ + ±
34 N-glycan: Man7D3 NGL h2 Maa-2Maa-6(Maa-3)Maa-6(Maa-2Maa-3)Mab-4GcNb-4GcN +++ + ±
35 N-glycan: Man8 NGL h3 Maa-2Maa-6(Maa-3)Maa-6(Maa-2Maa-2Maa-3)Mab-4GcNb-
4GcN
++ + ±
36 N-glycan: Man9 NGL h4 Maa-2Maa-6(Maa-2Maa-3)Maa-6(Maa-2Maa-2Maa-3)Mab-
4GcNb-4GcN
+++ ++ ±
37 N-glycan: Man3F NGL h5 Maa-6(Maa-3)Mab-4GcNb-4(Fua-6)GcN + ± ±
38 N-glycan: A2 NGL i1 SAa-6Gab-4GcNb-2Maa-6(SAa-6Gab-4GcNb-2Maa-3)Mab-
4GcNb-4GcN
± ± +/±
39 N-glycan: NA2 NGL i2 Gab-4GcNb-2Maa-6(Gab-4GcNb-2Maa-3)Mab-4GcNb-4GcN ± ± ±
40 N-glycan: NGA2 NGL i3 GcNb-2Maa-6(GcNb-2Maa-3)Mab-4GcNb-4GcN + ± ±
41 N-glycan: NA3-Lex NGL i4 Fua{Gab-4GcNb-2Maa-6[Gab-4GcNb-2(Gab-4GcNb-4)Maa-
3]Mab-4GcNb-4GcN}
+ ± ±
42 O-glycan: fucosylated NGL i5 (Fu)2.(Hx)2.(HxN)4 (BSM fraction N6) ++ + +/±
43 O-glycan: SA-fucosyl NGL j1 SA.Fu.Hx.(HxN)3 (BSM fraction A6) ± ± +/±
44 O-glycan: sialyl NGL j2 SA.(HxN)2 (BSM fraction A4) ± ± +/±
45 LNT NGL j3 Gab-3GcNb-3Gab-4Gc ± ± ±
46 LNnT NGL j4 Gab-4GcNb-3Gab-4Gc ± ± +/±
47 A-tri NGL j5 GaNa-3(Fua-2)Ga + ± +/±
48 B-penta NGL k1 Gaa-3(Fua-2)Gab-4(Fua-3)Gc + ± ±
49 H (LNFP I) NGL k2 Fua-2Gab-3GcNb-3Gab-4Gc ± ± +/±
50 Lea (LNFP II) NGL k3 Gab-(Fua-4)3GcNb-3Gab-4Gc ++ ++ ±
51 Lex (LNFP III) NGL k4 Gab-(Fua-3)4GcNb-3Gab-4Gc ++ + +/±
52 Leb (LNDFH I) NGL k5 Fua-2Gab-(Fua-4)3GcNb-3Gab-4Gc ++ +++ ±
53 Ley (LNnDFH I) NGL l1 Fua-2Gab-(Fua-3)4GcNb-3Gab-4Gc ++ + ±
54 3¢-SA-Lea-5 NGL l2 SAa-3Gab-3(Fua-4)GcNb-3Gab-4Gc + + ±
55 3¢-SA-Lex-5 NGL l3 SAa-3Gab-4(Fua-3)GcNb-3Gab-4Gc ± ± ±
56 3¢-SU-Lea-5 NGL l4 Ga(3SU)b-3(Fua-4)GcNb-3Gab-4Gc + + ±
57 3¢-SU-Lex-5 NGL l5 Ga(3SU)b-4(Fua-3)GcNb-3Gab-4Gc ++ + ±
58 3¢,6-SU-Lex-5 NGL m1 Ga(3SU)b-4(Fua-3)GcN(6SU)b-3Gab-4Gc + ± ±
59 6-SU-3¢-SA-Lex-5 GL m2 SAa-3Gab-3(Fua-4)GcN(6SU)b-3Gab-4Gc ± ± ±
60 6¢-SU-3¢-SA-Lex-5 GL m3 SAa-3Ga(6SU)b-3(Fua-4)GcNb-3Gab-4Gc ± ± ++
61 3¢,6¢-SU-Lex-5 NGL m4 Ga(6SU)b-(Fua-3)4GcN(3SU)b-3Gab-4Gc + + +
62 6¢-SU-Lex-5 NGL m5 Ga(6SU)b-(Fua-3)4GcNb-3Gab-4Gc ± ± ++
63 6¢-SA-Lex-5 GL n1 Ga(6SA)b-(Fua-3)4GcNb-3Gab-4Gc ± ± ±
64 6¢-SU-LNnT NGL n2 Ga(6SU)b-4GcNb-3Gab-4Gc + ± ++
65 HNK-1 GL n3 GcA(3SU)b-3Gab-4GcNb-3Gab-4Gc - ± ±
66 Man5-phosphate NGL n4 Ma(6PA)a-3Maa-3Maa-3Maa-2Ma ++ ± ±
67 CSA 2mer NGL n5 DUA-3GaN(4SU) ± ± ±
68 CSA 14mer NGL o1 DUA-[3GaN(4SU)b-4GcAb]6-3GaN(4SU) ± ± ±
69 CSB 2mer NGL o2 DUA-3GaN(4SU) + + +/±
70 CSB 14mer NGL o3 DUA-[3GaN(4SU)b-4IdAa]6-3GaN(4SU) ± ± +/±-
71 CSC 2mer NGL o4 DUA-3GaN(6SU) ++ + ±
72 CSC 14mer NGL o5 DUA-[3GaN(6SU)b-4GcAb]6-3GaN(6SU) ± ± ±
73 HS/HEP 2mer NGL p1 DUA(2SU)-4GcNSU(6SU) ± ± ±
74 HS/HEP 8mer NGL p2 UA-[GcN-UA]3-anMa ± ± ±
75 KS 4mer (C4U) NGL p3 SAa-3Gab-4(Fua-3)GcN(6SU)b-3Ga(6SU)b-4GcN(6SU) ± ± ±
76 dextran-Glc4 NGL p4 Gca-6Gca-6Gca-6Gc ± ± ±
77 dextran-Glc5 NGL p5 Gca-6Gca-6Gca-6Gca-6Gc ± ± ±
78 dextran-Glc6 NGL q1 Gca-6Gca-6Gca-6Gca-6Gca-6Gc ± ± ±
79 dextran-Glc7 NGL q2 Gca-6Gca-6Gca-6Gca-6Gca-6Gca-6Gc ± ± ±
80 Chitotriose NGL q3 GcNb-4GcNb-4GcN + ± +/±
aAbbreviations for type of lipid-linked oligosaccharides: NGL, neoglycolipid; GL, glycolipid.
bRefers to location on array.
cAbbreviations for monosaccharide residues and substituents: anMa, anhydro-mannose; Fu, fucose; Ga, galactose; GaN, N-
acetylgalactosamine; Gc, glucose; GcA, glucuronic acid; GcN, N-acetylglucosamine; Hx, hexose; HxN, N-acetylhexosamine; IdA, iduronic
acid; Ma, mannose; PA, phosphate; SA, sialic acid; SU, sulfate; UA, hexuronic acid; DUA, 4,5-unsaturated hexuronic acid. Oligosaccharides
42±44 and the glycosaminoglycan oligosaccharide fractions 67±75 are heterogeneous. Compositions (given with a dot `.' inserted between
monosaccharide residues) or sequences of the main components are shown here.
dSemi-quantitative visual score for binding signals detected: +++, very strong; ++, strong; +, moderate; +/±, weak; ±, not detected.
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C-terminus of murine IgG Fc (43). The fused cDNA constructs
were inserted into the pCMV expression vector (BD
Biosciences Clontech, Palo Alto, CA) and transfected onto
mammalian cell lines such as 293 and CHO cells. The
transfected cells were selected to stably express and secrete
the soluble fusion proteins under G418 selection (1 mg/ml).
These soluble C-type lectin±IgG fusion proteins were af®nity
puri®ed (Fig. 1) from the culture medium of mammalian cells,
as previously described (43). The full length murine SIGN-R1
was expressed in CHO cells as previously described (26).
Murine IgG±Fc and CHO cells transfected with pCMV vector
alone (CHO-Neo) served as controls.
Binding of recombinant soluble proteins to carbohydrates
arrayed on nitrocellulose
Polysaccharides, glycoproteins and neoglycoproteins, 0.5 mg
of each (in water/methanol 1:1), and lipid-linked oligosac-
charides, 10 pmol of each (in chloroform/methanol/water
25:25:8 by volume) were applied onto nitrocellulose mem-
branes, and binding experiments were performed at ambient
temperature as described previously (36). In brief, the mem-
branes were blocked for 1 h with 1% casein w/v in 10 mM Tris
HCl buffer pH 7.4 containing 50 mM calcium chloride and
150 mM NaCl, and overlaid for 2 h with the recombinant
proteins, 1 mg/ml, precomplexed (44) by incubation for 1 h with
biotinylated anti-mouse IgG from Jackson laboratories (1:3
ratio of protein to antibody w/w). Binding was detected by
colour development with streptavidin-conjugated horseradish
peroxidase (Sigma), followed by FAST-diaminobenzidine
(Sigma).
Binding of soluble proteins to lipid-linked oligosaccharides
immobilized in microwells
Lipid-linked oligosaccharides, 10±80 pmoles per well (in
methanol containing 4 mg egg lecithin and cholesterol/ml),
were dried down in 96-well microwell plates (Falcon 3912,
Marathon Labs, London, UK) overnight at 37°C. Binding
experiments were performed at ambient temperature as
described previously (44). In brief, wells were blocked for 1 h
with 1% casein w/v in 10 mM Tris HCl buffer pH 7.4 containing
2 mM CaCl2 and 150 mM NaCl and recombinant proteins,
50 ng/well, precomplexed (44) with biotinylated anti-mouse
IgG, (protein to antibody ratio 1:3 w/w), were added to the
wells. Incubation was for 2 h. Binding was detected by colour
development with streptavidin-conjugated horseradish per-
oxidase, followed by O-phenyldiamine (both from Sigma).
Inhibition of microwell binding of soluble SIGN-R1 to
mannose-BSA by monosaccharide conjugates and
polysaccharides
BSA-Man, or BSA-Gal as a negative control (0.5 mg/well) was
dried down overnight at 37°C in 96-well microwell plates, and
binding experiments with pre-complexed soluble recombinant
SIGN-R1were performed at ambient temperature as descri-
bed above. For inhibition experiments, binding of the SIGN-R1
was carried out in the presence of varying concentrations of
BSA±monosaccharide conjugates, or the polysaccharides
mannan, Ficoll and dextran 2000 kDa, or diluent alone. The
percentage of inhibition of binding in the presence of inhibitors
was determined as follows:
%Inhibition = [(OD with no inhibitor ± OD negative control) ±
(OD with inhibitor± OD negative control)] / [(OD no inhibitor ±
OD negative control)] 3 100
Staining of transfected CHO cells with monosaccharide-
and polysaccharide-conjugates
For ¯ow cytometry experiments, cells were suspended at 2 3
106 cells/ml in ¯ow cytometry buffer consisting of 20 mM
Hepes-buffered saline (HBS) containing 2 mM CaCl2 and
0.1% w/v BSA; all dilutions and washing steps were carried out
using this buffer. Twenty microlitres of cell suspension and
50 ml of FITC±dextran 2000 kDa, 24 mg/ml (®nal concentration
of 10 mg/ml) or mannose±PAA biotin or galactose±PAA±biotin,
120 mg/ml (®nal concentration of 50 mg/ml) and 50 ml of ¯ow
cytometry buffer were added to Falcon 2052 tubes and
incubated for 1 h on ice or at 37°C as indicated. The cells were
washed twice at 4°C (all subsequent washing steps were
carried out at 4°C). In the experiments on ice, cells that had
been incubated with mannose- or galactose±PAA±biotin were
further incubated for 30 min with 50 ml of FITC-conjugated
streptavidin, 10 mg/ml (Becton Dickinson, Oxford, UK) and
washed twice. In experiments carried out at 37°C with cells
that had been incubated with mannose- or galactose±PAA±
biotin, the cells were ®xed and permeabilized with 100 ml
Leukoperm reagent (Serotec, Kidlington, UK) and washed
once before the addition of the streptavidin±FITC. Staining of
cells was detected using a FACvantage cell sorter (Becton
Dickinson). For inhibition experiments, cells were ®rst incu-
bated for 30 min with 50 ml of 20 mM EDTA or 10 mg/ml ERTR9
antibody, or varying concentrations of monosaccharide,
oligosaccharide or polysaccharide inhibitors (at 4°C or 37°C
as appropriate) before addition of 50 ml FITC±dextran or
mannose±PAA±biotin. Oligosaccharide inhibitors were tested
as lipid-linked compounds displayed on liposomes (45).
Liposomes displaying galactosyl ceramide (Gal-ceramide),
or no oligosaccharide (empty liposomes) were included as
Fig. 1. Coomassie blue stains of the puri®ed recombinant soluble
proteins. The puri®ed samples of the four soluble mouse (m) IgG Fc
fusion proteins were analysed in a 4±15% gradient SDS±PAGE gel
after boiling for 5 min in 2-mercaptoethanol containing SDS±PAGE
buffer.
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negative control inhibitors. The percentage of inhibition of
binding in the presence of inhibitors was determined as
follows:
% Inhibition = [(MF of cells without inhibitors ±
MF of cells with inhibitors) / MF of cells stained without
inhibitors] 3 100
where MF = median ¯uorescence.
Scatchard type analyses of the binding of dextran- and
mannose-conjugates to transfected CHO cells
For Scatchard type analyses, SIGN-R1-transfected CHO cells,
or CHO-Neo cells as controls, were suspended at 2 3 106
cells/ml in ¯ow cytometry buffer. Twenty microlitres of cell
suspensions were placed in Falcon 96 well U-shaped tubes,
and incubated for 1 h on ice in the presence of the following:
50 ml of biotinylated dextran at concentrations from 360 to
3.8 mg/ml (®nal concentrations of 150±1.6 mg/ml) or biotinyl-
ated mannose±PAA, 240 mg/ml to 1.9 mg/ml (®nal concentra-
tion of 100±0.8 mg/ml) and 50 ml of ¯ow cytometry buffer. Total
reaction volume was 120 ml. The plates were spun at 300 g for
5 min, and the supernatants harvested. The concentrations of
the total conjugates added, and of the free conjugates after
incubation were assayed by determining biotin concentra-
tions, using a sensitive competitive inhibition assay (46), and
extrapolating from standard curves that we constructed for the
two biotinylated conjugates. The bound values for the SIGN-
R1 transfectants were calculated after subtracting bound
values for the CHO-Neo cells. The values were converted to
molar concentrations of monosaccharides for Scatchard
analyses to calculate the dissociation constants (Kds) for the
two conjugates, taking the carbohydrate content of the
dextran polysaccharide as 99% and of the mannose-PAA as
20%.
Staining of cell monolayers
For experiments with cell monolayers, 2 3 105 CHO-SIGN-R1
cells or CHO-Neo cells in 1 ml of culture medium (DMEM
containing 10% v/v foetal bovine serum, 100 mg of antibiotic±
antimycotic solution, and 1 mg of geneticin; all from Invitrogen,
Paisley, UK) were seeded in Nunc 4-well chamberslides
(Fisher Scienti®c, UK) and cultured for 2±3 days to reach 70±
80% con¯uency. Medium was removed from wells and cells
were washed twice; all dilutions and subsequent washing
steps were carried out with this buffer. For dual staining with
mannose conjugate and dextran, cells were incubated for 1 h
at 37°C with mannose±PAA±biotin, and FITC±dextran at 50
and 10 mg respectively per ml. Cells were washed twice, and
®xed with 1 ml of 1% v/v paraformaldehyde for 15 min at 4°C.
Cells were permeabilized by incubating with 1 ml of 0.2% v/v
Triton X-100 for 20 min at 4°C, and washed twice. Cells were
then incubated for 30 min at 4°C with Cy3 labelled
streptavidin, 10 mg/ml, and washed twice. Cells were mounted
with Vector Hardset ¯uorescent mountant, for microscopic
visualization of staining using a Leica TCS NT confocal
microscope with a 1003 objective (magni®ed digitally to
10003).
Results
Binding of the soluble SIGN-R1 protein to glycoconjugates
arrayed on membranes
The soluble SIGN-R1 gave binding signals with the mono-
saccharides mannose, fucose and N-acetylglucosamine con-
jugated to BSA (Table 1 and Fig. 2). Among the six
glycoproteins arrayed, ribonuclease B, invertase, soybean
agglutinin, ovalbumin, fetuin and asialo-fetuin (Table 1), four
are known to have high mannose chains. SIGN-R1 gave
binding signals with three of these: invertase, soybean
agglutinin and ovalbumin (Fig. 2A, b5, c1 and c2, respect-
ively). Of the polysaccharides tested, yeast mannan was
bound; but the neutral dextrans and Ficoll were notable by
their lack of binding signals with SIGN-R1 (Fig 2A). Only the
dextran sulfate was strongly bound; another acidic polysac-
charide, heparan sulfate, was not bound.
The recognition of mannose-, fucose- and N-acetylglucos-
amine-terminating oligosaccharides was also apparent for
SIGN-R1 in the binding detected with the arrayed lipid-linked
oligosaccharides (Table 2, Fig. 3A). With the high mannose
type N-glycans that were tested in the array, the Man3 (g1)
Fig. 2. Binding of recombinant soluble proteins to monosaccharide-
conjugates, glycoproteins and polysaccharides immobilized on
nitrocellulose membranes. The glycoconjugates (Table 1) were
spotted onto nitrocellulose membranes and overlaid with the
recombinant soluble fusion proteins, SIGN-R1 (A), SIGN-R3 (B) and
langerin (C), and as a control, mouse IgG Fc (D), which had been
pre-complexed with biotinylated anti-mouse-IgG; binding was
detected as described in Methods. The three spots, those of
soybean agglutinin (c1) ¯uorescein-labelled and FITC- and TR-
conjugated dextrans (e3 and f1, respectively) showing binding with
the control protein, IgG Fc, as well as the chimeric proteins are
asterisked; of these only soybean agglutinin was bound by the three
receptors more strongly than by the control protein.
858 Carbohydrate arrays and ligands of SIGN-R1, -R3 and langerin
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on July 10, 2014
http://intim
m
.oxfordjournals.org/
D
ow
nloaded from
 
gave a weaker signal than Man4±Man9 (g2-h4, respectively).
With the fuco-oligosaccharides, the linkage position of the
fucose residue was important: binding was not observed to
the blood group H type oligosaccharide with fucose 2-linked
to galactose (k2), whereas strong binding was detected to the
neutral oligosaccharides of Lea/b and Lex/y types with fucose 3-
or 4-linked to N-acetylglucosamine (k3, k4, k5 and l1).
Sialylation at position 3 or 6 of galactose or sulfation of the
Lea and Lex sequences at position 3 or 6 of galactose or
position 6 of N-acetylglucosamine (l2 to n1) did not enhance
the SIGN-R1 binding; the binding was either weakened or
unaffected.
Binding was also examined to arrayed oligosaccharides
derived from dextran: 4-, 5-, 6-, and 7-mers. No binding was
detected in accord with the lack of binding to preparations of
the intact polysaccharide (Fig. 3A, locations p4 to q2
respectively).
Binding of the soluble SIGN-R1 protein to oligosaccharides
immobilized in microwells
The microwell binding experiments validated results with the
arrayed oligosaccharides (Fig. 4AA¢). They showed, in addi-
tion, a clear correlation between binding signal and mannose
number in the N-glycans tested. The results also showed that
SIGN-R1 binding to the neutral Lea- and Lex-type oligosac-
charides was of the same order as to the high mannose
N-glycans Man7 and Man9. There was little binding to the
6-mer, dextran oligosaccharide.
The lack of detectable interaction of the soluble SIGN-R1
with dextran and Ficoll, was corroborated by inhibition of
binding experiments in microwells (Fig. 5). Dextran and Ficoll
gave no inhibition of SIGN-R1 binding to the mannose±BSA
conjugate (Fig. 5A), whereas mannan was inhibitory.
Comparisons of the binding of the soluble SIGN-R3 and
langerin proteins with SIGN-R1
Comparisons of the saccharide binding of SIGN-R3 and
langerin with that of SIGN-R1 showed only subtle differences
with SIGN-R3 but striking differences with langerin as follows.
SIGN-R3 showed binding to the monosaccharide mannose-
and fucose-conjugates, and among the glycoproteins, there
was binding to invertase and soybean agglutinin (Fig. 2B,
locations b5 and c1 and Table 1). Among the polysac-
charides, as with SIGN-R1, there was SIGN-R3 binding to the
sulfated dextran but not the neutral dextrans. SIGN-R3
showed stronger binding to Lea/b-related sequences than to
Lex/y (Fig. 3B and 4B).
With langerin, there was binding to the dextran sulfate.
Binding to the mannosyl probes was barely detectable in the
arrays (Figs 2C and 3C; Table 1), and not in the microwell
assay (Fig. 4C). The non-acidic Lewis-related sequences also
gave little or no binding (Figs 3C and 4C¢). The striking
difference of langerin from SIGN-R1, and also SIGN-R3, was a
clear preference of langerin for binding to sulfated Lex-related
sequences (oligosaccharides 60±62) with sulfation at position
6 of galactose, designated 6¢-sulfated Lex (Fig. 3C, m3 to m5
and Fig. 4C¢). This indicates that where there is a terminal
6¢-sulfated galactose, the fucose residue is not essential for
langerin binding.
Fig. 3. Binding of recombinant soluble proteins to lipid-linked oligosaccharides immobilized on nitrocellulose membranes. Lipid-linked
oligosaccharides (Table 2) were spotted onto nitrocellulose membranes and overlaid with the recombinant soluble fusion proteins SIGN-R1
(A), SIGN-R3 (B) and langerin (C), which had been pre-complexed with biotinylated anti-mouse IgG; binding was visualized as described in
Methods.
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Binding experiments with mannose conjugate and
¯uorescein labelled dextran and cells transfected to express
SIGN-R1
Having detected no dextran binding by the soluble SIGN-R1
protein, it was important to reconcile with the earlier observa-
tions (26) on the membrane-associated form of the receptor
mediates dextran. We examined by ¯ow cytometry CHO cells
that had been transfected to express the membrane associ-
ated SIGN-R1. There was staining of the SIGN-R1-transfected
cells with FITC±dextran not only at 37°C as described
previously (26) but also at 4°C (Fig. 6A, panels i and ii).
Another ¯uorescein-conjugated probe, ¯uorescein-conju-
gated galactose±BSA, gave no staining (Fig. 6A, vii and viii).
The SIGN-R1-CHO cells gave staining also with mannose±
PAA conjugate (Fig. 6B, i and ii), but not with the galactose
analog (Fig. 6B, vii and viii). Speci®city of FITC±dextran and
mannose conjugate staining was further corroborated by lack
of staining of the CHO-Neo cells, transfected with the vector
only (Fig. 6B, ix and x).
Fig. 4. Binding of recombinant soluble proteins to lipid-linked oligosaccharides immobilized in microwells. Varying amounts of lipid-linked
oligosaccharides were dried down in microwells and probed with recombinant fusion proteins SIGN-R1 (A and A¢), SIGN-R3 (B and B¢), and
langerin (C and C¢), which had been pre-complexed with biotinylated anti-mouse-IgG; binding was detected as described in Methods. Results
are expressed as the means of duplicate wells with the range indicated by error bars. A and A¢ are results of a single experiment; B, B¢, C and
C¢ are results of different experiments.
Fig. 5. Inhibition of binding of recombinant soluble SIGN-R1 to
mannose±BSA by mannan and monosaccharide conjugates.
Mannose±BSA, 10 mg/ml, was dried down in microwells and probed
with soluble SIGN-R1 (precomplexed with biotinylated anti-mouse
IgG) in the presence of varying concentrations of mannan, Ficoll and
dextran 2000 kDa (A) and monosaccharide conjugates (B). Binding
was detected as described in Methods. Results are expressed
as the means of duplicate wells with the range indicated by error
bars.
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The staining both with the dextran- and mannose-
conjugates was cation dependent, being inhibited in the
presence of EDTA, as predicted for a C-type lectin. The
staining with the mannose- as well as the dextran-conjugates
was inhibited in the presence of the SIGN-R1 antibody, ERTR9
(Fig. 6A and B, iii±vi).
To gain further insights into the relationship between the
dextran and mannose binding to the SIGN-R1-transfected
cells, the cells were incubated with dextran- and mannose-
conjugates at 37°C, and their distribution examined by
confocal microscopy. The staining was predominantly intra-
cellular, and the majority of the staining with the two
conjugates was concordant (Fig. 7). There was negligible
staining in the non-transfected cells (data not shown).
A series of inhibition experiments was performed with
mono-, oligo- and polysaccharides (Fig. 8). Both the dextran
and mannose conjugate staining were inhibitable by mannan
and other carbohydrate ligands identi®ed for the soluble
SIGN-R1. These include the monosaccharides mannose and
fucose, a high mannose N-glycan, Man-7D1, the Lea- and Lex-
related sequences, and dextran sulfate. Other charged
polysaccharides, heparin and heparan sulfate, were not
inhibitory. However, only the FITC±dextran staining, but not
the mannose staining, was inhibited to a signi®cant extent by
the neutral dextran 2000 kDa.
Collectively, the concordant intracellular staining with the
mannose and dextran conjugates, the inhibitory activities of
the anti-SIGN-R1 antibody shown in Fig. 6, together with the
IC50 values (concentrations giving 50% inhibition of binding)
summarized in Table 3, indicate that both the mannose and
dextran binding are mediated by the cell-associated SIGN-R1,
but that the dextran binding is more readily inhibitable than the
mannose binding: mannan is over 10 000-fold more active
than dextran at inhibiting FITC±dextran binding.
Scatchard type analysis of the mannose- and
dextran-binding to SIGN-R1 transfected cells
At the suggestion of one of the reviewers of our manuscript, we
performed additional cell binding experiments for Scatchard
type analyses, to compare the avidities of binding of the
mannose±PAA conjugate and dextran to SIGN-R1-transfected
cells. We have duly carried out Scatchard analyses using the
biotinylated mannose±PAA and a biotinylated dextran (Fig. 9),
although it must be noted that the carbohydrate presentation
Fig. 6. Flow-cytometric analyses of the staining of transfected CHO cells with monosaccharide- and dextran-conjugates. CHO-SIGN-R1 cells
were incubated with FITC±dextran 2000 kDa (Dex-F) (A) or with mannose±PAA±biotin conjugate (Man-P) (B) at 4°C or at 37°C in the absence
or presence of 20 mM EDTA or 10 mg/ml of anti-SIGNR1 antibody (ERTR9). As negative controls, CHO-SIGN-R1 cells were incubated with
galactose±PAA±biotin (Gal-P) or FITC±galactose BSA conjugate (Gal-F) and CHO-Neo cells with Man-P or Dex-F.
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is different in the two glycoconjugates. The dissociation
constants thus generated for the mannose and the dextran
conjugates are 9 3 10±6 M and 5 3 10±3 M, respectively. These
results support our conclusion that the avidity of interaction of
dextran with the membrane-associated SIGN-R1 is low, and it
is substantially lower than that of the mannose conjugate.
Discussion
We describe here the use of arrays of an extensive panel of
carbohydrates for discovering ligands of three novel receptors
of the immune system. The arrays encompass glycoproteins,
polysaccharides, monosaccharides and oligosaccharides,
Fig. 8. Flow-cytometric analyses of inhibition of staining of SIGN-R1-transfected CHO cells with mannose- and dextran-conjugates using as
inhibitors, monosaccharides, and polysaccharide and lipid-linked oligosaccharides. For inhibition experiments, CHO-SIGN-R1 cells were
incubated for 30 min with the monosaccharides, mannose, fucose or galactose, at ®nal concentrations of 10±100 mg/ml or with the
polysaccharides mannan, dextran or dextran-sulfate polysaccharides, at ®nal concentrations of 0.03±1 mg/ml (A and B) or with liposomes
displaying Man-7D1, Lex, Lea, SuLex or Su-Lea oligosaccharides, ®nal concentrations of 0.3±30 mM, (A¢ and B¢). Staining with mannose±PAA±
biotin, ®nal concentration 50 mg/ml or with FITC±dextran 2000 kDa, 10 mg/ml was then performed at 4°C as described in Methods. Results are
expressed as percentage inhibition of staining by the mannose conjugate (A and A¢), or dextran conjugate (B and B¢). The four panels are
each the results of separate experiments.
Fig. 7. Confocal microscopic analysis of the intracellular distribution of mannose- and dextran-conjugates taken up by SIGN-R1-transfected
cells. To examine intracellular distribution of the mannose- and dextran-conjugates, monolayers of SIGN-R1 transfected cells were stained for
1 h with FITC±dextran, 10 mg/ml (A) and mannose±PAA±biotin, 50 mg/ml (B) at 37°C. An overlay of the cellular distribution of the two
conjugates is shown in (C).
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including an extensive list of N-glycans. Quantitative ELISA-
type binding and inhibition experiments corroborate the
readout in the arrays.
The salient conclusions, with the soluble recombinant forms
of the three murine receptors, SIGN-R1, SIGN-R3 and
langerin, are ®rst, that both SIGN-R1 and SIGN-R3 exhibit
mannose- and fucose-related recognition. This is in common
with several other C-type carbohydrate-binding proteins of the
innate immune system (3,13,14,16). The mannose recognition
is manifest by their interactions with invertase, soybean
agglutinin and with the high mannose N-glycans; the fucose
recognition is manifest with the Lea- and Lex-related sequen-
ces, with SIGN-R3 showing a clear preference for Lea over Lex.
The two receptors contrast with the selectins (4,44,47±51) in
that they do not show enhanced binding to sialyl and sulfated
forms of the Lea and Lex. Moreover, mannose speci®city is not
a feature of the selectins (36). These receptors also differ from
the macrophage C-type lectin (MGL) on monocyte-derived
immature dendritic cells (52), which has speci®city for
oligosaccharides that terminate in galactose or N-acetyl-
galactosamine. Rather, the binding speci®cities we observe
for the soluble forms of SIGN-R1 and SIGN-R3 resemble that
of the human DC-SIGN (14) and partially overlap with those of
the collectins (53), which were assigned using a limited
number of oligosaccharide probes. The second major ®nding
in the array experiments is the speci®city of langerin toward
Lex-type sequences that are sulfated at position 6 of the outer
galactose, particularly oligosaccharide compound 60 (6¢-SU-
3¢-SA-Lex-5). This speci®city is unique so far among the
C-type lectins, and contrasts very markedly with the selectins,
which bind to the Lex analog that has sulfate at position 3 of
galactose, but not the analog with sulfate at position 6 of
galactose (36,49,54). The 6¢-SU-3¢-SA-Lex-5 was strongly
bound by the soluble form of langerin. High-mannose glycans
were weakly bound, as shown for the soluble form of the
receptor in earlier studies (16). Thirdly, the three proteins, in
soluble form, show binding to dextran-sulfate, but not at all to
unmodi®ed dextran.
The eukaryotically expressed soluble receptors of the type
used here, IgG Fc chimeras, have the advantage over
bacterially expressed proteins in that refolding and enrich-
ment by ligand af®nity chromatography is not usually a
prerequisite and the carbohydrate arrays can thus be probed
without the need to predict binding activity or speci®city. An
additional advantage of IgG Fc chimeras is that the dimeric
proteins can be readily rendered oligomeric in the presence of
anti-Fc, a system ®rst introduced for the selectins, e.g. (55).
This strategy may not be a complete substitute, however, for
multimeric presentation of the receptors at the surface of cells
(26), with an optimally orientated presentation that would allow
interactions with low af®nity ligands. This is illustrated here with
SIGN-R1-transfected CHO cells, and in preliminary studies
with SIGN-R3- and langerin-transfected cells (data not
shown). Interactions with dextran could not be detected at
all with the soluble proteins either by binding or inhibition of
binding experiments, but could be detected when the proteins
were expressed at the surface of cells. Dextran uptake by
cells transfected with SIGN-R3 and langerin has been shown
by independent experiments (56). There was weak binding of
Fig. 9. Scatchard type plot of the interactions of biotinylated dextran
and mannose and mannose±PAA to SIGN-R1 transfected cells. To
determine dissociation constants for the interactions of biotinylated
dextran and mannose±PAA with SIGN-R1 transfected CHO cells,
different concentrations of the biotinylated conjugates were
incubated with the CHO-SIGN-R1 and CHO-neo transfectants for 1 h
on ice, and the cell supernatants harvested for assays of biotin
concentration, as described in Methods. From the biotin
concentrations added to the cells and the concentrations of free
biotin in the cell supernatants, the amounts of bound and free
conjugates were calculated, after subtraction of the non-speci®c
binding of the conjugates to CHO-neo cells. Results are expressed
as Scatchard type plots for biotinylated mannose±PAA (A) and the
biotinylated dextran (B). The conjugates bound are given on the
x-axis as mM of monosaccharides, and the ratios of bound/free, on
the y-axis; using the mean values from quadruplicate wells, except
for the 0.004 mM bound concentration that was from duplicate wells.
Table 3. Inhibitory activities of monosaccharides, oligo-
saccharides and polysaccharides toward the staining of
CHO-SIGN-R1 cells with mannose- and dextran-conjugates
Inhibitors Staining with
mannose-conjugate
Staining with
dextran-conjugate
IC50 (mg/ml)
Monosaccharides
Mannose n.i.a 23 000
Fucose 33 000 18 000
Galactose n.i. ~100 000
Oligosaccharides (NGLs)
Man7D1 <0.69 (< 0.6 mM) <0.69 (< 0.6 mM)
Lex 4.95 (5.8 mM) 5.79 (7 mM)
Lea 1.54 (1.8 mM) 3.41 (4 mM)
3¢-SU-Lex-5 4.29 (4.6 mM) <0.56 (0.6 mM)
3¢-SU-Lea-5 1.77 (1.9 mM) <0.56 (0.6 mM)
Polysaccharides
Mannan 0.25 <0.03
Dextran 2000K n.i. 560
Dextran SU-500K 85 30
Heparin n.i. n.i.
Heparan sulfate n.i. n.i.
Negative controls
Gal-ceramide n.i. n.i.
Empty liposomes n.i. n.i.
an.i. = no inhibition or <50% inhibition at the highest concentration
tested: 100 mg/ml for monosaccharides, 1 mg/ml for
polysaccharides and 30 mM for the galactosylceramide, and empty
liposomes, in which DHPE was used instead of NGL or glycolipid.
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soluble langerin-IgG to glycoconjugates with high-mannose
glycans, whereas langerin-transfected cells bound strongly to
a mannose conjugate and ovalbumin (our data not shown)
(56). Thus, the two experimental approaches with the soluble
and the cell-associated proteins complement one another; the
soluble proteins lending themselves to surveys of binding
to large numbers of carbohydrate probes, and the cell-
associated proteins enabling detection of ligands of very low
avidity that are not detectable with the soluble proteins even
after arti®cial oligomerization.
The cell staining experiments with the SIGN-R1-trans-
fectants in the present investigation have shown that the
monosaccharide ligands, as well as oligosaccharide and
polysaccharide ligands of this receptor can inhibit the dextran
binding. Thus the dextran binding is likely to be mediated by
the site that also binds mannose and fucose. The cyto-
chemical experiments with SIGN-R1 transfectants to visualize
and compare the uptake at 37°C of dextran- and mannose-
conjugates, also showed the relatedness of the SIGN-R1
interactions with the two conjugates. At 1 h after incubation,
the two conjugates were largely co-localized in intracellular
compartments. Collectively, these data, and the ease of
inhibition of dextran binding compared with inhibition of
mannose-conjugate binding, as well as the results of
Scatchard analyses lead to the conclusion that dextran is a
ligand for SIGN-R1, but that its avidity is low.
Knowledge of the oligosaccharide sequences recognized
by the murine receptors on antigen presenting cells now
opens the way to examining experimentally the immunological
sequelae of the interactions of the receptors with de®ned
ligands of differing af®nities. The way is also open to the
inhibition of lectin-mediated uptake of pathogens, whereby
they reach protected cell compartments and evade immune
recognition and clearance. The overlaps in carbohydrate
structures recognized by several of the receptors should not
preclude such studies, as it is possible to design ligand
presentations that are preferred by individual receptors
(15,57). There is precedent for striking differences between
carbohydrate binding receptors in recognition of a given
oligosaccharide ligand (a high-mannose type N-glycan, Man9
for example) presented on different carrier proteins and also
on the same proteins such as ribonuclease B before and after
its denaturation (58,59). Two of the serum proteins of the
innate immune system, conglutinin and mannan binding
protein, bind avidly to the clustered Man9 N-glycan in the
absence of carrier proteins (60,61). However, only conglutinin
binds to the complement glycopeptide, iC3b, a proteolytic
fragment of the glycoprotein C3, which bears a high-mannose
N-glycan, predominantly Man9, at a single glycosylation site
(58). The carrier protein has been shown to have a major
in¯uence on the availability of the N-glycan, as conglutinin
does not bind to the parent C3 glycoprotein. Conglutinin can
only bind after a proteolytic cleavage occurs of the glycopro-
tein in the complement cascade and conversion into iC3b.
With re®nements in carbohydrate ligand presentation, in
conjunction with gene deletions of the individual receptors, it
will be possible to address the roles of the individual C-type
lectins in the immune response, and above all to revisit and
dissect pathways in the orchestration of T-independent anti-
body responses, this time using de®ned oligosaccharides as
immunogens.
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